These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4977944)

  • 21. 4-[(Aminoalkyl)amino]-1,2-dimethoxynaphthalenes as antimalarial agents.
    Archer S; Osei-Gyimah P; Silbering S
    J Med Chem; 1980 May; 23(5):516-9. PubMed ID: 6770088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of laboratory and clinical data during treatment of leprosy.
    Pattyn SR; Rollier R; Rollier MR; De Muynck A; Janssens PG; Verdoolaeghe-Van Loo G
    Ann Soc Belg Med Trop; 1972; 52(6):537-48. PubMed ID: 4574223
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of sulphone resistant leprosy--a review of sixty one cases.
    Seshadri PS; Ravi NT
    Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123
    [No Abstract]   [Full Text] [Related]  

  • 24. The treatment of leprosy with the sulfones. I. Faget's original 22 patients. A thirty-year follow-up on sulfone therapy for leprosy.
    Jacobson RR; Trautman JR
    Int J Lepr Other Mycobact Dis; 1971; 39(3):726-37. PubMed ID: 4948221
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening of drug resistant strains of Mycobacterium leprae in lepromatous leprosy patients under multidrug treatment.
    Sreevatsa ; Girdhar BK; Desikan KV
    Indian J Med Res; 1988 Feb; 87():139-43. PubMed ID: 3294170
    [No Abstract]   [Full Text] [Related]  

  • 26. Ciprofloxacin (4-quinolone) and Mycobacterium leprae.
    Banerjee DK
    Lepr Rev; 1986 Jun; 57(2):159-62. PubMed ID: 2943954
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis of analogs of 6-arylthio-, 6-arylsulfinyl-, and 6-arylsulfonyl-2, 4-diaminoquinazolines as potential antimalarial agents.
    Hynes JB; Ashton WT; Merriman HG; Walker FC
    J Med Chem; 1974 Jul; 17(7):682-4. PubMed ID: 4600305
    [No Abstract]   [Full Text] [Related]  

  • 28. Antileprosy drugs.
    Br Med J; 1971 Jul; 3(5767):174-6. PubMed ID: 4104273
    [No Abstract]   [Full Text] [Related]  

  • 29. The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
    Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL
    Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of the first oral bioprecursors of bis-alkylguanidine antimalarial drugs.
    Degardin M; Wein S; Duckert JF; Maynadier M; Guy A; Durand T; Escale R; Vial H; Vo-Hoang Y
    ChemMedChem; 2014 Feb; 9(2):300-4. PubMed ID: 24403182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
    Almeida JG
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
    [No Abstract]   [Full Text] [Related]  

  • 32. The chemotherapy of leprosy. Part 2.
    Ellard GA
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):82-94. PubMed ID: 2030319
    [No Abstract]   [Full Text] [Related]  

  • 33. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 34. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
    Browne SG
    Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and biological activity of some di(nitrothienyl)- and di(acetylaminothienyl)sulfones.
    Ronsisvalle G; Vittorio F; Pappalardo MS
    Farmaco Sci; 1983 Nov; 38(11):877-83. PubMed ID: 6360709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Committee 4: workshop on experimental chemotherapy of leprosy.
    Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):297-303. PubMed ID: 378876
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of leprosy.
    Lancet; 1971 Sep; 2(7723):534-5. PubMed ID: 4105673
    [No Abstract]   [Full Text] [Related]  

  • 38. SULPHONE RESISTANCE IN LEPROSY. AN EXPERIMENTAL AND CLINICAL STUDY.
    PETTIT JH; REES RJ
    Lancet; 1964 Sep; 2(7361):673-4. PubMed ID: 14188912
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug resistance of Mycobacterium leprae].
    Pattyn SR
    Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
    [No Abstract]   [Full Text] [Related]  

  • 40. Rifampin-resistant leprosy.
    Jacobson RR; Hastings RC
    Lancet; 1976 Dec; 2(7998):1304-5. PubMed ID: 63780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.